Last reviewed · How we verify

NCT07040735

Low-Flow Anesthesia and Open-Heart Surgery

Not yet recruiting Last updated 3 July 2025
What this trial tests

trial in Low-flow Anesthesia in 80 participants. Not yet recruiting.

Timeline
1 July 2025
Primary endpoint
1 January 2026
1 February 2026

Quick facts

Lead sponsorÇağrı Özdemir
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment80
Start date1 July 2025
Primary completion1 January 2026
Estimated completion1 February 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Çağrı Özdemir

Who can join

18 and older, any sex, with Low-flow Anesthesia or Hemodynamics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low-flow anesthesia (LFA) is a technique in which at least 50% of the exhaled air, after carbon dioxide absorption, is mixed with a certain amount of fresh gas and returned to the patient during the next inspiration. In 1974, R. Virtue defined minimal flow anesthesia (MFA) as 0.5 L/min. In 1984, Baker and Simionescu classified LFA as 0.5-1 L/min and MFA as 0.25-0.5 L/min. The aim of this study is to investigate whether there are hemodynamic differences between open-heart surgery cases performed with LFA at different fresh gas flow rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Çağrı Özdemir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07040735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing